Abstract: An ovel metabolomics approach for NMR-based stable isotope tracer studies called PEPAi sp resented, and its performance validated using human cancer cells.PEPAdetects the position of carbon label in isotopically enriched metabolites and quantifies fractional enrichment by indirect determination of 13 C-satellite peaks using 1D-1 H-NMR spectra. In comparison with 13 C-NMR, TOCSY and HSQC,P EPA improves sensitivity,accelerates the elucidation of 13 Cpositions in labeled metabolites and the quantification of the percentage of stable isotope enrichment. Altogether,P EPAp rovides an ovel framework for extending the high-throughput of 1 H-NMR metabolic profiling to stable isotope tracing in metabolomics,f acilitating and complementing the information derived from 2D-NMR experiments and expanding the range of isotopically enriched metabolites detected in cellular extracts.
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Nuclear magnetic resonance (NMR) and mass spectrometry are the primary analytical tools used to profile metabolite levels in biological samples. [1] However, the steady-state concentration of metabolites is not sufficient to study the regulation of cellular metabolism. Elucidating the flow of chemical moieties through the complex set of metabolic reactions that happen in the cell is essential for understanding the regulation of metabolic pathways. [2] Fort hat, stable isotope tracer studies are needed, which usually require model cell lines that are fed as table isotopically labeled substrate.D ue to the unique ability of NMR to characterize isotopomers of metabolites by detecting labeling patterns in individual atoms, 13 C-NMR in combination with selective 13 Cstable isotope tracers have traditionally been used to analyze 13 Cenrichment in isolated metabolites [3] and biological crude mixtures, [4] [5] [6] enabling models of metabolic flux to be generated. [7] Thea dvent of comprehensive metabolic profiling technologies has broadened the coverage of these studies allowing for an unbiased mapping of fluxes through multiple metabolic pathways. [8] Thes o-called stable isotope resolved metabolomics (SIRM) [9, 10] has emerged as ap owerful untargeted approach to classical 13 C-NMR-based stable isotope tracing studies.N MR-based SIRM primarily uses homonuclear 2D 1 H-1 HTOCSY (total correlation spectroscopY) and heteronuclear 2D 1 H- 13 CH SQC (heteronuclear single-quantum correlation) for analyzing isotopomers in crude cell extracts, [11] [12] [13] [14] NMR-acquisition times necessary to obtain suitable TOCSY or HSQC spectra for SIRM applications are two to three orders of magnitude higher than 1D-1 H-NMR. Even so,s ensitivity issues with respect to enriched metabolites in complex biological extracts and technical complexity in data acquisition and interpretation have limited the application of 2D-NMR for isotope tracer studies.T hus, NMR-based SIRM is rather often used to obtain qualitative inputs on one or few samples,w hereas quantitative information on larger sample sets is obtained via complementary mass spectrometry isotopologue analysis. [8, 15] To make NMR more accessible to comprehensive metabolic analyses,wehave developed anew methodology called PEPA( positional enrichment by proton analysis). PEPA detects the position of carbon label in isotopically enriched metabolites and quantifies their fractional enrichment in 1D-1 H-NMR spectra. In principle,t he ability of 1D-1 H-NMR to observe 13 C-satellite peaks makes it suitable for tracer studies. [3] However,d irect quantification of 13 C-satellites in 1D-1 H-NMR spectra of cell extracts is generally only possible for af ew metabolites characterized by well-resolved resonances with recognizable 13 C-satellite peaks such as lactate and alanine. [16] Thev ast majority of 13 13 C-edited 1 HNMR offers an alternative method for carbon tracking studies. [17] However,t he difficulty to filter highintensity 12 Cs ignals,t he partial or complete resonance overlap of 13 Cs atellites in complex biological mixtures,a nd the lack of databases with labeled compounds,m akes the untargeted profiling of enriched metabolites very problematic.Altogether this has prevented the use of 1D-1 H-NMR for comprehensive isotope tracer studies.PEPAcircumvents this limitation by indirectly determining 13 C-satellites from the decayed central peak area observed in 1D-1 H-NMR spectra of biological equivalent replicates of labeled experiments as compared to the spectra acquired from unlabeled controls (Scheme 1a nd Figure S5 in the Supporting Information). According to PEPA, the area of 13 C-satellite peaks in 1D-1 H-NMR spectra can be indirectly determined as detailed in Equation (1):
where I represents ac entral peak area in each biological replicate exposed to labeled substrate,and " I is the mean area of the same central peak from all unlabeled replicates.T he fractional 13 Ce nrichment for each resonance in the 1D-1 H-NMR can be calculated as detailed in Equation (2) (see also Supporting Information for adetailed discussion):
Consequently,b yi ndirect determination of 13 C-satellites areas,P EPAg oes beyond classical assessment of labeled metabolites by NMR and it significantly widens the coverage of the metabolic network that can be investigated using 1D-1 H-NMR.
U2OS osteosarcoma cells were used as ac ellular model for the implementation of PEPA. U2OS cells were subjected during 6hours to culture medium containing 13 C-enriched substrates (either uniformly labeled glucose [U-
13 C]-Glc or uniformly labeled glutamine [U-
13 C]-Gln) or to culture medium with unlabeled substrates (each condition was run in triplicate,see Supporting Information for details). Overall, 84 different resonances underlying 46 polar metabolites were identified in 1D-1 H-NMR spectra (Table S1 ) using BBioref AMIX database from Bruker,C henomx, HMDB [18] and complex mixture analysis by NMR (COLMAR) [19] leading to the metabolic network coverage shown in Figure S4 . The area of 1D-1 H-NMR resonances in Table S1 were quantified using DOLPHIN, [20] as pectral library-guided line shapefitting and deconvolution algorithm specially developed for quantifying partially overlapped and poorly resolved 1D-1 H-NMR resonances ( Figure S1 and S2) . Among the 84 proton resonances profiled in the 1 H-NMR spectra, we determined via statistical testing that 37 resonances showed significant decays in the central peak area in samples that were fed as table isotopically labeled substrate ( Figure S3 ). Figure 1 depicts fractional enrichments calculated according to Equation (2) for these 37 resonances.
According to PEPA, metabolic fates of [U-13 C]-Glc were found in the riboside C1',g lucose anomeric C1'' and uracil ring C5 and C6 positions of UDP-Glucose,U DP-Glucuronate,U DP-GlcNAc and UDP-GalNAc. TheC 1 '-riboside position was also found enriched in cytidine and adenosine nucleotides (AXP,where Xrefers to the number of phosphate groups). AXP,inaddition, showed 13 C-labeling in C2 and C8 positions of the adenine ring. Finally,t he metabolic fate of labeled glucose was also found in glycine(CH 2 ); glycerol-(CH 2 -OH);g uanidoacetate(CH 2 -OH);g lutamate g(CH 2 ); C]-Glc into the glycolysis, tricarboxylic acid cycle,p entose phosphate pathway,g lycine metabolism, hexosamine pathway and both purine and pyrimidine biosynthetic pathways ( Figure S4 and S5) . On the other hand, the main metabolic fates of [U-
13 C]-Gln were found in fumarate (CH) and succinate (CH 2 ), both accounting for 99 %a nd 79 %f ractional enrichment in mean, respectively. 13 C-atoms from [U-
13
C]-Gln were also incorporated in aspartate b(CH 2 )a nd in C5 and C6 positions of uracil in pyrimidine nucleotides,s uggesting de novo synthesis of pyrimidine ring from aspartate.F inally,t he fate of [U-
13 C]-Gln was detected in glutamate g(CH 2 )/a(CH) and glutathione a(CH)/b(CH 2 ), indicating activation of glutaminolysis and biosynthesis of glutathione in this cancer cell line ( Figure S5) .
In order to confirm PEPAsr esults, 13 C-NMR and 2D-edited NMR experiments (TOCSY,HSQC and HMBC) were acquired on representative sample extracts grown either in unlabeled or labeled substrates. (Figure 2A) . In [U-
13 C]-Glc experiments ( Figure 2B ), the 13 C-cross-peaks patterns around the central unlabeled peaks of H1'-H3'-cytidine (gray) and H1'-H2'-uridine (green) correlations, confirmed the predicted isotopic enrichment of such metabolites in C1' position by PEPA. In [U-
13 C]-Gln experiments, the 13 C-cross peak pattern around the central H5-H6 correlation peak of uridine in the TOCSY spectrum (Figure 2C )c onfirms the isotopic enrichment of C5 position of the uracil ring determined by PEPA. Altogether,u ridine serves as agood example that dispersal of carbon flux across ar ange of metabolic substructures may determine the regulation of many metabolites that are assembled from these substructures. [21] Noteworthy,e ach of the 37 positional 13 C-enrichments observed by PEPAc ould only be qualitatively confirmed using ac ombination of 13 C-NMR and 2D-edited NMR experiments (all spectra are available in MetaboLights with accession number MTBLS247;T able S2 shows the structural assignments). Many of the positional enrichments in Figure 1 were confirmed using 13 C-NMR. Thea nalysis of splitting patterns (i.e., multiplicities in 13 C-NMR and 13 C-cross-peaks in TOCSY spectra) is useful to highlight some constraints of PEPA. As with TOCSY and HSQC,P EPAc annot estimate enrichment at non-protiated sites.T he composition of positional isotopomers can neither be elucidated using PEPA. For instance,t he analysis of 13 C-NMR splitting patterns of aspartate-b(CH 2 )a nd glutamate(gCH 2 /bCH 2 )f rom cells cultured in [U-
13 C]-Glc revealed various 13 C-positional isotopomers.This information enables elucidating the number of turns of the TCA cycle.Itisnonetheless also true that PEPA detected significant 13 C-enrichments in metabolites with either symmetric or non-correlated protons,i ncluding fumarate,s uccinate,g uanidoacetate and acetates,a ni nformation that cannot be otherwise detected using TOCSY experiments. Thecarbon labels of these metabolites were confirmed using HSQC spectra acquired on labeled sample extracts and contrasting them with HSQC spectra from unlabeled equivalent replicates.Occasionally,despite decays of central peaks, the statistical test used to determine differences between labeled and unlabeled equivalent samples do not always reach the conventional significance threshold value.This is the case of lactate and alanine.T he former showed consistent central peak decays of C3 (À1.32 fold-change at d1.33 ppm) and C2 (À1.20 fold-change at d4,11 ppm). Thel atter showed C3 central peak decay (À1.27 fold-change at d1.46 ppm). This is due to the variability within and between labelled and unlabeled samples,w hich we mainly attribute to metabolite extraction methods and natural biological variability of cell culture replicates,i nthat order. [22] In summary,P EPAt akes advantage of the sensitivity, robustness,quantitativeness,high-throughput capabilities and ease-to-implement of 1D-1 H-NMR to study the position of carbon labels in large sample sets.Here we proved that PEPA can span the range of isotopically enriched metabolites detected in cellular extracts over 13 C-NMR and 2D-edited experiments.P EPAg reatly simplifies NMR untargeted carbon fate tracking and complements the information derived from 2D-NMR and 13 C-NMR. Further experiments by 2D NMR and 13 C-NMR on the compounds initially screened by PEPAm ay enable am ore comprehensive isotopomer and isotopologue characterization, including non-protiated sites.A ltogether,P EPAw ill accelerate the implementation of NMR in cell metabolism studies.
